Performance Assessement for Paralympic Athletes (PARAPERF)
Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports
The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.
The secondary objectives of the study:
- quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
- quantification and mechanical monitoring by the made-to-measure or usual sportive material.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Tipo de estudo
Tipo de estudo
Inscrição (Antecipado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Jean François Toussaint, MD, PhD
- Número de telefone: +33 (0)1 42 34 82 10
- E-mail: jean-francois.toussaint@aphp.fr
Estude backup de contato
- Nome: François Genêt, MD, PhD
- Número de telefone: +33 (0)1.47.10.70.68
- E-mail: francois.genet@aphp.fr
Locais de estudo
-
-
-
Garches, França, 92380
- Recrutamento
- Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
- Aged >= 14 years;
- Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
- Covered by social security system.
Exclusion Criteria:
- Temporary or definitive contraindication to the practice of the affected sport activity;
- Undergoing anti-coagulated treatments;
- Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
- Under guardianship or judicial decision;
- Ongoing pregnancy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Outro: Parasportives of various disciplines
|
Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Dynamic sportive activity
Prazo: through study completion, an average of 1 year
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
through study completion, an average of 1 year
|
|
Dynamic sportive activity
Prazo: at 42 months
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
at 42 months
|
|
Static sportive activity
Prazo: through study completion, an average of 1 year
|
Static sportive activity: maximal speed of movement of pression center.
|
through study completion, an average of 1 year
|
|
Static sportive activity
Prazo: at 42 months
|
Static sportive activity: maximal speed of movement of pression center.
|
at 42 months
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Biomechanical indices of performance: isometric power measurement
Prazo: through study completion, an average of 1 year
|
Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
|
through study completion, an average of 1 year
|
|
Biomechanical indices of performance: arms and shoulder's Strength
Prazo: through study completion, an average of 1 year
|
Arms and shoulder's Strength will be measured by force platform.
|
through study completion, an average of 1 year
|
|
Physiological indices of performance: maximal aerobic speed (MAS)
Prazo: Twice through study completion, an average of 42 months
|
Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
|
Twice through study completion, an average of 42 months
|
|
Physiological indices of performance: maximal aerobic power
Prazo: Twice through study completion, an average of 42 months
|
Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
|
Twice through study completion, an average of 42 months
|
|
Fatigue assessment
Prazo: Twice through study completion, an average of 42 months
|
Fatigue assessment will be measured by Fatigue Index (Power max ratio).
|
Twice through study completion, an average of 42 months
|
|
Blood lactate concentration
Prazo: immediately after the intervention
|
Blood lactatemia level will be measured by lactometer.
|
immediately after the intervention
|
|
VO2 peak oxygen uptake
Prazo: through study completion, an average of 1 year
|
VO2 peak oxygen uptake
|
through study completion, an average of 1 year
|
|
Peak breath expiration volume assessment
Prazo: through study completion, an average of 1 year
|
VE peak: peak breath expiration volume
|
through study completion, an average of 1 year
|
|
Peak cardiac frequence
Prazo: through study completion, an average of 1 year
|
CF: peak cardiac frequence
|
through study completion, an average of 1 year
|
|
Musculo-squeletic troubles risks measurement
Prazo: through study completion, an average of 1 year
|
Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e.
"Constant scale").
|
through study completion, an average of 1 year
|
|
Time and distance of deceleration of wheelchair during riding test
Prazo: through study completion, an average of 1 year
|
Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
|
through study completion, an average of 1 year
|
|
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion
Prazo: through study completion, an average of 1 year
|
Applied forces on handrim during the propulsion: measured by force platform.
|
through study completion, an average of 1 year
|
|
Acceleration profil during the propulsion
Prazo: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
|
Speed profil during the propulsion
Prazo: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: François Genêt, MD, PhD, Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
- Diretor de estudo: Jean François Toussaint, MD, PhD, Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Antecipado)
Conclusão Primária
Conclusão do estudo (Antecipado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
Outros números de identificação do estudo
- APHP201139
- 2020-A02919-30 (Identificador de registro: IDRCB)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .